-
-
-
-
-
-
-
Catalyst Pharmaceuticals (CPRX) Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE
-
-
-
-
-
-
-
Catalyst Pharmaceuticals (CPRX) Announces Upcoming CEO Retirement
-
-
-
-
-
-
-
Catyalyst Pharma (CPRX) says no decision has been received from FDA on NDA for Firdapse
-
-
-
-
-
-
-
Catyalyst Pharma (CPRX) Reports FDA Acceptance of NDA and Priority Review Status for Firdapse for Lambert-Eaton Myasthenic Syndrome
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

